Teva CEO to retire
Executive Summary
Teva CEO Israel Makov, 67, will retire in 2007, he announces Oct. 18. Makov will be succeeded by Shlomo Yanai, who has served as CEO of Makhteshim Agan Industries since 2003. During Makov's tenure as CEO, Teva's sales increased four-fold to approximately $8.5 bil., and Teva became the world's largest generics manufacturer with the $7.8 bil. acquisition of Ivax (1"The Pink Sheet" Aug. 1, 2005, p. 19)...